Guardion Health Sciences Inc (NASDAQ:GHSI) shares saw strong trading volume on Friday . 7,725,883 shares were traded during mid-day trading, an increase of 99% from the previous session’s volume of 3,888,153 shares.The stock last traded at $0.20 and had previously closed at $0.18.
The firm’s 50 day moving average price is $0.24 and its 200-day moving average price is $0.75. The company has a debt-to-equity ratio of 0.06, a current ratio of 13.36 and a quick ratio of 12.66.
Guardion Health Sciences (NASDAQ:GHSI) last announced its quarterly earnings data on Thursday, November 14th. The company reported ($0.07) earnings per share (EPS) for the quarter. The company had revenue of $0.16 million during the quarter. Guardion Health Sciences had a negative return on equity of 186.27% and a negative net margin of 922.62%.
Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.
Further Reading: What is a stock portfolio tracker?
Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.